Tag: RootsAnalysis
The RNAi therapeutics market is anticipated to grow at an annualized rate of more than 45%, till 2030, claims Roots Analysis
The RNAi therapeutics market is anticipated to grow at an annualized rate of more than 45%, till 2030, claims Roots Analysis
The “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030
The “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030
With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030
With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030
With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion
With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030
The “STING Pathway Targeting Therapeutics and Technologies, 2020-2030
The “STING Pathway Targeting Therapeutics and Technologies, 2020-2030
Many small / macro molecule-based STING pathway modulators are currently being evaluated
Many small / macro molecule-based STING pathway modulators are currently being evaluated
The STING pathway targeting technologies market is projected to grow at an annualized rate of ~25%,
The STING pathway targeting technologies market is projected to grow at an annualized rate of ~25%, till 2030
The STING pathway targeting technologies market, featuring a healthy pipeline of therapeutics
The STING pathway targeting technologies market, featuring a healthy pipeline of therapeutics
More than 100 subcutaneous biologics have been approved and over 350 such drug candidates
More than 100 subcutaneous biologics have been approved and over 350 such drug candidates
The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by
The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030
The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion
The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030
The “Synthetic Lethality-based Drugs and Targets Market, 2019-2030
The “Synthetic Lethality-based Drugs and Targets Market, 2019-2030
The “Targeted Protein Degradation Market
The “Targeted Protein Degradation Market, 2020-2030
More than 85 small molecule protein degraders are currently being evaluated for the treatment
More than 85 small molecule protein degraders are currently being evaluated for the treatment
The targeted protein degradation market is projected to grow at an annualized rate of more than 30%
The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030
